Artivion, Inc.
NYSE:AORT
32.7 (USD) • At close August 7, 2025
Overzicht | Financiële gegevens
| Bedrijfsnaam | Artivion, Inc. |
| Symbool | AORT |
| Munteenheid | USD |
| Prijs | 32.7 |
| Beurswaarde | 1,396,381,560 |
| Dividendpercentage | 0% |
| 52-weken bereik | 21.97 - 33.39 |
| Industrie | Medical Devices |
| Sector | Healthcare |
| CEO | Mr. James Patrick Mackin |
| Website | https://artivion.com |
An error occurred while fetching data.
Over Artivion, Inc.
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita Open Plus and
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)






